Large deletion of the X-linked lymphoproliferative disease gene detected by fluorescence in situ hybridization

American Journal of Hematology

Volumn 64, Issue 2, 2000, Pages 128-132

  Honda, K ^a   Kanegane, H ^b   Eguchi, M ^c   Kimura, H ^d   Morishima, T ^d   Masaki, K ^e   Tosato, G ^f   Miyawaki, T ^b   Ishii, E ^a  

^a HAMANOMACHI HOSPITAL   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Chidoribashi Byoin   (Japan)

^f CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Fluorescence In situ hybridization; Gene deletion; SAP gene; X linked lymphoproliferative disease

Indexed keywords

ARTICLE; B CELL LYMPHOMA; CASE REPORT; CHILD; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE MUTATION; HEMOPHAGOCYTIC SYNDROME; HUMAN; HUMAN CELL; HYPOGAMMAGLOBULINEMIA; IMMUNE DEFICIENCY; INFECTIOUS MONONUCLEOSIS; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL; X CHROMOSOME LINKED DISORDER;

EID: 0034034070     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-8652(200006)64:2<128::aid-ajh11>3.0.co;2-%23     Document Type: Article

References (20)

1. Purtilo DT, Grierson HL. Methods of detection of new families with X-linked lymphoproliferative disease. Cancer Genet Cytogenet 1991; 51:143-153.
2. Seemayer TA, Grierson H, Pirruccello SJ, Gross TG, Weisenburger DD, Davis J, Spiegel K, Brichacek B, Sumegi J. X-linked lymphoproliferative disease. Am J Dis Child 1993;147:1242-1245.
3. Seemayer TA, Gross TG, Egeler RM, Pirruccello SJ, Davis JR, Kelly CM, Okano M, Lanyi A, Sumegi J. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr Res 1995;38:471-478.
4. Wyandt HE, Grierson HL, Sanger WG, Skare JC, Milunsky A, Purtilo DT. Chromosomal deletion of Xq25 in an individual with X-linked lymphoproliferative disease. Am J Med Genet 1989;33:426-430.
5. Sanger WG, Grierson HL, Skare J, Wyandt H, Pirruccello S, Fordyce R, Purtilo DT. Partial Xq25 deletion in a family with the X-linked lymphoproliferative syndrome (XLP). Cancer Genet Cytogenet 1990; 47:163-169.
6. Schuster V, Kress W, Freidrich W, Grimm T, Kreth HW. X-linked lymphoproliferative disease. Detection of a paternally inherited mutations in a German family using haplotype analysis. Am J Dis Child 1993;147:1303-1305.
7. Grierson GL, Skare J, Church J, Silberman T, Davis JR, Kobrinsky N, McGregor R, Israels S, McCarty J, Andrews LG, Blecha S, Erdman S, Obringer A, Scharnhorst D, Purtilo DT. Evaluation of families wherein a single male manifest a phenotype of X-linked lymphoproliferative disease (XLP). Am J Med Genet 1993;47:458.
8. Schuster V, Seidenspinner S, Grimm T, Kreß W, Zielen S, Bock M, Kreth HW. Molecular genetic haplotype segregation studies in three families with X-linked lymphoproliferative disease. Eur J Pediatr 1994;153:432-437.
9. Coffey AJ, Brooksbank RA, Brandau O, Oohashi T, Howell GR, Bye JM, Cahn AP, Durham J, Heath P, Wray P, Pavitt R, Wilkinson J, Leversha M, Huckle E, Shaw-Smith CJ, Dunham A, Rhodes S, Schuster V, Porta G, Yin L, Serafini P, Sylla B, Zollo M, Franco B, Bolino A, Seri M, Lanyi A, Davis JR, Webster D, Harris A, Lenoir G, de St Basile G, Jones A, Behloradsky BH, Achatz H, Murken J, Fassler R, Sumegi J, Romeo G, Vaudin M, Ross MT, Meindl A, Bentley DR. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain-encoding gene. Nat Genet 1998;20:129-135.
10. Nichols KE, Harkin DP, Levitz S, Krainer M, Kolouist KA, Genovese C, Bernard A, Ferguson M, Zuo L, Snyder E, Buckler AJ, Wise C, Ashley J, Lovett M, Valentine MB, Look AT, Gerald W, Housman DE, Haber DA. Inactivation mutations in an SH2-domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci USA 1998;95:13765-13770.
11. Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D, van Schaik S, Notarangelo L, Geha R, Roncarolo MG, Oettgen H, De Vries JE, AvErsa G, Terhorst C. The X-linked lymphoproliferative gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998;395:462-469.
12. Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S, Matsuyama T, Morishima T. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 1999;37: 132-136.
13. Bohlander SK, Espinosa R III, Fernald AA, Rowley JD, Le Beau MM, Diaz MO. Sequence-independent amplification and labeling of yeast artificial chromosomes for fluorescence in situ hybridization. Cytogenet Cell Genet 1994;65:108-10.
14. Arif M, Tanaka K, Subrahmanyan T, Kumaravel S, Eguchi M, Iwato K, Dohy H, Kamada N. Detection of residual host cells in sexmismatched bone marrow transplantation in various hematological disease by fluorescence in situ hybridization. Jpn J Cancer Res 1997; 88:420-426.
15. Ochs H, Sullivan JL, Wedgwood RJ, Seeley JK, Sakamoto K, Purtilo DT. X-linked lymphoproliferative syndrome: abnormal antibody responses to bacteriophage φX174. Birth Def 1983;19:321-323.
16. Kanegane H, Kanegane C, Yachie A, Miyawaki T, Tosato G. Infectious mononucleosis as a disease of early childhood in Japan caused by primary Epstein-Barr virus infection. Acta Paediatr Jpn 1997;39:166-171.
17. Skare J, Milunsky A, Byron KS, Sullivan J. Mapping the X-linked lymphoproliferative syndrome. Proc Natl Acad Sci USA 1987;84: 2015.
18. Skare J, Wu B-L, Madan S, Pulijaal V, Purtilo DT, Haber D, Nelson D, Sylla B, Grierson H, Nitowsky H. Characterization of three overlapping deletions causing X-linked lymphoproliferative disease. Genomics 1993;16:254-255.
19. Filipovich AH, Blazar BR, Ramsay NK, Kersey JH, Zelkowitz L, Harada S, Purtilo DT. Allogeneic bone marrow transplantation for X-linked lymphoproliferative syndrome. Transplantation 1986;42: 222-224.
20. Vowels MR, Lam-Po-Tang R, Berdoukas V, Ford D, Thierry D, Purtilo D, Gluckman E. Correction of X-linked lymphoproliferative disease by transplantation of cord-blood stem cells. Lancet 1993;329: 1623.